[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Lanxess: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market

October 2010 | 43 pages | ID: B229E2205B2EN
Venture Planning Group

US$ 1,520.00 US$ 1,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global PDF: US$ 4,100.00

A strategic assessment of Bayer/Lanxess, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.

Contains 43 pages and 7 tables
I. EXECUTIVE SUMMARY

II. BUSINESS ORGANIZATION

III. SENIOR MANAGEMENT

IV. FACILITIES AND EMPLOYEES

V. TECHNOLOGICAL KNOW-HOW

VI. PRODUCT PORTFOLIO

VII. MARKETING TACTICS

VIII. SALES AND PROFIT GROWTH

IX. R&D EXPENDITURES AND MAJOR PROGRAMS

X. COLLABORATIVE ARRANGEMENTS

LIST OF TABLES


Table 1: Bayer Sales by Business Segment
Table 2: Bayer Sales Growth by Business Segment
Table 3: Bayer Sales by Geographic Region
Table 4: Bayer Sales Growth by Geographic Region
Table 5: Lanxess Sales and Operating Profit Growth
Table 6: Lanxess Sales by Product Line
Table 7: Lanxess Sales Growth by Product Line


More Publications